RxDoctor Payments Data

Edward Kelly, MD

Family Medicine · Downingtown, PANPI 1235122300

Payments from drug & device makers

$8,542in general payments, 2019–2025

Across 515 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Pfizer$798
  • Novo Nordisk$712
  • GSK$638
  • Lilly USA, LLC$632
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$8,512100%
  • Education$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,542 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$121,169
Medicare patients
230
Services billed
1,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab22$144,080
EliquisApixaban233$132,894
MounjaroTirzepatide54$63,109
JardianceEmpagliflozin67$53,188
Oxymorphone Hcl ErOxymorphone Hcl12$49,819
OzempicSemaglutide37$41,285
Breztri AerosphereBudesonide/Glycopyr/Formoterol44$32,745
XareltoRivaroxaban20$31,143
FarxigaDapagliflozin Propanediol24$29,036
OxycontinOxycodone Hcl11$28,947
JanuviaSitagliptin Phosphate39$25,661
TrulicityDulaglutide13$14,397
Janumet XrSitagliptin Phos/Metformin Hcl11$13,841
Synjardy XrEmpagliflozin/Metformin Hcl17$13,754
Xultophy 100-3.6Insulin Degludec/Liraglutide11$13,650

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$798$143,773267 claims
Lilly USA, LLCMounjaro, Trulicity$632$77,50767 claims
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr$218$74,15496 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$1,253$67,33487 claims
Novo NordiskOzempic, Xultophy 100-3.6$712$54,93548 claims
MerckJanuvia, Janumet Xr$348$39,50250 claims
Johnson & JohnsonXarelto$70$31,14320 claims
GSKTrelegy Ellipta$638$10,54716 claims
AbbVieLinzess$1,434$7,36114 claims
Astellas Pharma US IncMyrbetriq$138$7,04716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Downingtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →